thorough QT

Related by string. Thorough QT * THOROUGH . Thorough : Thorough QT studies . thorough vetting . thorough scrubbing . thorough frisking . thorough examination . thorough inspection . Thorough informative . thorough handwashing / Qt . QTS . qt . QTD : Qt SDK . QT interval . Usual QT . QT interval prolongation . KDE Qt . QT prolongation . Trolltech Qt . Qualifying Transaction QT * Thorough QT TQT . Thorough QT Study *

Related by context. Frequent words. (Click for all words.) 69 Randomized controlled 68 phase IIa 68 Phase Ib clinical 68 GSK# [001] 67 placebo controlled clinical 67 active comparator 67 pharmacokinetics PK 66 dose titration 65 phase IIb clinical 64 double blinded placebo 64 nonrandomized 64 phase IIb 64 Phase 2a trial 64 pharmacodynamic effects 64 Phase 1b clinical 64 prospective multicenter 63 placebo controlled Phase 63 RHUCIN 63 Traficet EN 63 PREZISTA r 63 bicifadine 63 pharmacokinetic PK 63 elotuzumab 63 Pivotal Phase III 63 AeroLEF TM 63 placebo controlled clinical trials 63 MIRCERA 63 Stedivaze 63 multicenter clinical 63 QTc 62 ICA # 62 DDP# 62 tasimelteon 62 analgesic efficacy 62 placebo controlled studies 62 Phenoptin 62 pharmacokinetic studies 62 Phase IIa trial 62 Genasense R oblimersen 62 nab paclitaxel 62 Phase Ia 62 PEG SN# 62 prospective randomized controlled 62 tanespimycin 62 Phase 1a 62 6R BH4 62 doripenem 62 TYGACIL 61 Phase 2a clinical 61 daptomycin 61 Fibrillex TM 61 alagebrium 61 liposomal formulation 61 Azedra 61 randomized controlled clinical trials 61 methylnaltrexone 61 ISTODAX 61 ILLUMINATE 61 Phase IIb clinical 61 Phase 1b trial 61 Sym# 61 confirmatory Phase III 61 multicentre 61 lumiracoxib 61 Multicenter 61 interferon beta 1b 61 BrachySil 61 Dasatinib 61 optimal dosing 61 PROMACTA 61 TOLAMBA 61 efficacy tolerability 60 KRN# 60 pharmacokinetic 60 diabetic neuropathic pain 60 renal toxicity 60 ascending doses 60 senicapoc 60 Zemiva 60 Phase 2b clinical 60 phase 2a 60 RRMS patients 60 SCH # 60 pharmacodynamics 60 DAVANAT 60 multicenter Phase 60 Phase 2a 60 concomitant medications 60 multicenter randomized 60 randomized controlled clinical 60 Phase IIa clinical 60 irbesartan 60 PRADAXA 60 #mg/day [001] 60 dose escalation trial 60 RSD# 60 tigecycline 60 pheochromocytoma 60 PS# [001] 60 IPLEX 60 OncoVEX GM CSF

Back to home page